Phase Ib Study of Navicixizumab Plus Paclitaxel in Patients With Platinum-Resistant Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Among 451 incident cases of papillary thyroid cancer and ...
CA-125 KELIM as a Potential Complementary Tool for Predicting Veliparib Benefit: An Exploratory Analysis From the VELIA/GOG-3005 Study This study includes the PanCareSurFup and ProCardio cohort of ≥ 5 ...
Investigators conducted a nested case-control study of women aged ≥ 40 years from the general population of Sweden for the years 2009-2019. Analyses assessed menopausal hormone therapy use among 943 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results